NOTCH1 is an inclusion criterion in 3 clinical trials for breast carcinoma, of which 1 is open and 2 are closed. Of the trials that contain NOTCH1 status and breast carcinoma as inclusion criteria, 2 are phase 1 (0 open) and 1 is phase 2 (1 open) [4].

NOTCH1 is an inclusion criterion in 2 clinical trials for adenoid cystic carcinoma, of which 2 are open and 0 are closed. Of the trials that contain NOTCH1 status and adenoid cystic carcinoma as inclusion criteria, 1 is phase 1 (1 open) and 1 is phase 2 (1 open) [4].

NOTCH1 is an inclusion criterion in 2 clinical trials for chronic lymphocytic leukemia/small lymphocytic lymphoma, of which 2 are open and 0 are closed. Of the trials that contain NOTCH1 status and chronic lymphocytic leukemia/small lymphocytic lymphoma as inclusion criteria, 2 are phase 2 (2 open) [4].

NOTCH1 is an inclusion criterion in 2 clinical trials for lymphoma, of which 0 are open and 2 are closed. Of the trials that contain NOTCH1 status and lymphoma as inclusion criteria, 2 are phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 2 clinical trials for malignant solid tumor, of which 0 are open and 2 are closed. Of the trials that contain NOTCH1 status and malignant solid tumor as inclusion criteria, 2 are phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for acute myeloid leukemia, of which 1 is open and 0 are closed. Of the trial that contains NOTCH1 status and acute myeloid leukemia as inclusion criteria, 1 is phase 2 (1 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for anaplastic astrocytoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and anaplastic astrocytoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for bladder carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and bladder carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for cholangiocarcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and cholangiocarcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for chronic lymphocytic leukemia, of which 1 is open and 0 are closed. Of the trial that contains NOTCH1 status and chronic lymphocytic leukemia as inclusion criteria, 1 is phase 2 (1 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for colon carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and colon carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for colorectal carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and colorectal carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for follicular lymphoma, of which 1 is open and 0 are closed. Of the trial that contains NOTCH1 status and follicular lymphoma as inclusion criteria, 1 is phase 2 (1 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for glioblastoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and glioblastoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for head and neck carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and head and neck carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for head and neck squamous cell carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and head and neck squamous cell carcinoma as inclusion criteria, 1 is phase 2 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for hodgkin lymphoma, of which 1 is open and 0 are closed. Of the trial that contains NOTCH1 status and hodgkin lymphoma as inclusion criteria, 1 is phase 2 (1 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for mantle cell lymphoma, of which 1 is open and 0 are closed. Of the trial that contains NOTCH1 status and mantle cell lymphoma as inclusion criteria, 1 is phase 2 (1 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for melanoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and melanoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for myelodysplastic syndrome with excess blasts-2, of which 1 is open and 0 are closed. Of the trial that contains NOTCH1 status and myelodysplastic syndrome with excess blasts-2 as inclusion criteria, 1 is phase 2 (1 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for myeloid neoplasm, of which 1 is open and 0 are closed. Of the trial that contains NOTCH1 status and myeloid neoplasm as inclusion criteria, 1 is phase 2 (1 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for non-small cell lung carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and non-small cell lung carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for ovarian carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and ovarian carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for pancreatic carcinoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and pancreatic carcinoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for sarcoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and sarcoma as inclusion criteria, 1 is phase 1 (0 open) [4].

NOTCH1 is an inclusion criterion in 1 clinical trial for soft tissue sarcoma, of which 0 are open and 1 is closed. Of the trial that contains NOTCH1 status and soft tissue sarcoma as inclusion criteria, 1 is phase 1 (0 open) [4].